Cholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and established ischaemic heart disease: is it cost-effective?

Cholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and established ischaemic heart disease: is it cost-effective?

OBJECTIVE: To measure the cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with established ischaemic heart disease and average baseline cholesterol levels. DESIGN: Prospective economic evaluation within a double-blind randomised trial (Long-Term Intervention with Pra...

Full description

Bibliographic Details
Main Authors:	Glasziou, P, Eckermann, S, Mulray, SE, Simes, R, Martin, A, Kirby, A, Hall, J, Caleo, S, White, H, Tonkin, A
Format:	Journal article
Language:	English
Published:	2002

Similar Items

Cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: results from the LIPID study.
by: Tonkin, A, et al.
Published: (2006)

Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study.
by: Colquhoun, D, et al.
Published: (2004)

Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up.
by: LIPID Study Group (Long-term Intervention with Pravastatin in Ischaemic Disease)
Published: (2002)

Monitoring cholesterol levels: measurement error or true change?
by: Glasziou, P, et al.
Published: (2008)

Pravastatin therapy and the risk of stroke.
by: White, H, et al.
Published: (2000)

Efficacy and safety of cholesterol-lowering treatment - Reply
by: Baigent, C, et al.
Published: (2006)

Efficacy and safety of cholesterol-lowering treatment - Reply
by: Baigent, C, et al.
Published: (2006)

Cholesterol level lowering liposomes
by: Pollock, S, et al.
Published: (2012)

Sibu olive inhibits artherosclerosis by cholesterol lowering effect in cholesterol fed-rabbit
by: M.H., Nurulhuda, et al.
Published: (2012)

Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease.
by: Reid, I, et al.
Published: (2001)

CHOLESTEROL LOWERING TRIALS IN THEIR EPIDEMIOLOGIC CONTEXT
by: Collins, R
Published: (1993)

Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations.
by: Chen, Z, et al.
Published: (1991)

Comparison of fat intake in Australian and New Zealand CHD patients: The LIPID (long term intervention with Pravastatin in ischaemic disease) study
by: Nestel, P, et al.
Published: (2002)

Randomised placebo controlled trial of effect on mood of lowering cholesterol concentration. Oxford Cholesterol Study Group.
by: Wardle, J, et al.
Published: (1996)

CHOLESTEROL-LOWERING TRIAL RESULTS IN THEIR EPIDEMIOLOGIC CONTEXT
by: Peto, R, et al.
Published: (1985)

Effects of lowering LDL cholesterol on progression of kidney disease.
by: Haynes, R, et al.
Published: (2014)

Plasma cholesterol, coronary heart disease, and cancer.
by: Peto, R, et al.
Published: (1989)

LOW CHOLESTEROL AND CORONARY HEART-DISEASE - REPLY
by: Chen, Z, et al.
Published: (1991)

Stroke, coronary heart disease, cholesterol and blood pressure
by: Lewington, S, et al.
Published: (1997)

Benefits of lowering cholesterol in chronic kidney disease Reply
by: Baigent, C, et al.
Published: (2011)

[Can cholesterol lowering treatment have unwanted effects?]
by: Karpe, F, et al.
Published: (1991)

Can cholesterol lowering treatment have unwanted effects?
by: Karpe, F, et al.
Published: (1991)

Efficacy and safety of more intensive lowering of LDL cholesterol Reply
by: Baigent, C, et al.
Published: (2011)

Efficacy and safety of more intensive lowering of LDL cholesterol Reply
by: Baigent, C, et al.
Published: (2011)

Cholesterol and lipids
by: Baigent, C, et al.
Published: (2008)

Garlic and cholesterol /
by: 466590 Ingels, Darin
Published: (1999)

Biology of cholesterol /
by: Yeagle, Philip
Published: (1988)

Cholesterol fractions and heart disease mortality in older men
by: Clarke, R
Published: (2008)

Physicians' perceptions of cholesterol management: From the heart study
by: Hobbs, R, et al.
Published: (2006)

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.
by: Baigent, C, et al.
Published: (2005)

Cholesterol and total mortality: need for larger trials.
by: Collins, R, et al.
Published: (1992)

Randomised placebo controlled trial of effect on mood of lowering cholesterol concentration
by: Wardle, J, et al.
Published: (1996)

OXIDATION KINETICSAND QUANTIFICATIONMETHODOF CHOLESTEROL USING CHOLESTEROL OXIDASE ENZYMECATALYST
by: Perpustakaan UGM, i-lib
Published: (2010)

The microsomal triglyceride transfer protein gene-493T variant lowers cholesterol but increases the risk of coronary heart disease.
by: Ledmyr, H, et al.
Published: (2004)

Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study.
by: Tonkin, A, et al.
Published: (2000)

The effect of lowering LDL cholesterol on vascular access patency: post hoc analysis of the Study of Heart and Renal Protection.
by: Herrington, W, et al.
Published: (2014)

Monitoring adherence to drug treatment by using change in cholesterol concentration: secondary analysis of trial data.
by: Bell, K, et al.
Published: (2011)

Monitoring adherence to drug treatment by using change in cholesterol concentration: Secondary analysis of trial data
by: Bell, K, et al.
Published: (2011)

The rise of cholesterol testing: how much is unnecessary.
by: Doll, H, et al.
Published: (2011)

The rise of cholesterol testing: how much is unnecessary?
by: Doll, H, et al.
Published: (2011)